RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
  Emergency Medicine
  Internal Medicine
  Respiratory Medicine
   Asthma
   COPD
   Cystic Fibrosis
  Sexual Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Systematic Review
The Cochrane Library
Asthma Channel

subscribe to Asthma newsletter
Latest Research : Medicine : Respiratory Medicine : Asthma

   EMAIL   |   PRINT
Inhale magnesium sulphate along with beta-2-agonists during asthma attacks

Jul 20, 2005 - 3:07:00 PM
They concluded that there was good evidence that nebulised magnesium sulphate was safe and effective and that it should be considered as an additional therapy along with beta-2-agonists.

 
[RxPG] Severe asthma attacks can be life threatening and intravenous magnesium sulphate is known to help, but inhaling nebulised magnesium sulphate can also improve lung function.

Asthma is a chronic disease of the lungs where people have periods where their breathing is stable, and other periods where it is restricted. These 'exacerbations' or 'attacks' can be mild or so severe that the person needs hospital treatment.

During most episodes people use inhaled beta-2-agonists, but in more severe cases these alone may not be enough to restore breathing to normal. The Cochrane Review Authors therefore searched the literature to examine the evidence regarding the use of inhaled magnesium sulphate as an additional therapeutic option.

They concluded that there was good evidence that nebulised magnesium sulphate was safe and effective and that it should be considered as an additional therapy along with beta-2-agonists.

"We also found that magnesium sulphate was most useful in situations where the exacerbation was severe," says lead author Maurice Blitz, who works in the Division of General Surgery, at the University of Alberta, Canada



Publication: Review Title: Blitz et al: Inhaled magnesium sulphate in the treatment of acute asthma. The Cochrane Database of Systematic Reviews 2005 Issue 3
On the web: www.interscience.wiley.com 

Advertise in this space for $10 per month. Contact us today.


Related Asthma News
Breast-feeding babies staves off asthma risk
Mannose receptor plays a key role in allergic responses to cat dander
MEMS sensor for remote monitoring of asthmatic patients
Inhaled treatments work better for asthmatic kids
A dog in home may worsen asthma in children
PEAK Trial: Inhaled steroids do not prevent chronic asthma
Telithromycin antibiotic could help in asthma attack
Tomatoes, carrots can cut asthma risk
Inhaled steroid may work better for normal-weight people
Female foetus could increase expectant woman's asthma

Subscribe to Asthma Newsletter

Enter your email address:


 Additional information about the news article
Cochrane reviews are based on the best available information about healthcare interventions. They explore the evidence for and against the effectiveness and appropriateness of treatments (medications, surgery, education, etc) in specific circumstances.

The complete reviews are published in The Cochrane Library which is available by subscription, either on CDROM or via the Internet. You should be able to browse the Cochrane Library at your nearest medical library if you don't have your own subscription.

The Cochrane Library is published four times a year. Each issue contains all existing reviews plus an increasingly wider range of new and updated reviews. It is published and distributed by Wiley InterScience and is also distributed by a number of other Distribution Partners. It is not available for sale from Cochrane Centres.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)